Real-world safety experience with Peanut (Arachis hypogaea) Allergen Powder-dnfp in 2500 children with peanut allergy

被引:0
|
作者
Jara, Michele [1 ]
Walker, Ekaterina [1 ]
Tilles, Stephen [1 ]
Anagnostou, Aikaterini [2 ]
机构
[1] Nestle Hlth Sci Co, Aimmune Therapeut, Brisbane, CA 94005 USA
[2] Texas Childrens Hosp, Dept Pediat, Div Immunol Allergy & Retrovirol, Houston, TX USA
关键词
ORAL IMMUNOTHERAPY;
D O I
10.1016/j.anai.2024.02.027
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
[No abstract available]
引用
收藏
页码:778 / 780
页数:3
相关论文
共 41 条
  • [41] Real-world experience with CLAIRYG® 50 mg/mL (intravenous immunoglobulin) in children under 12 years with primary immunodeficiency or immmune thrombocytopenia: a post-approval safety study
    Mahlaoui, Nizar
    Fouyssac, Fanny
    Mazingue, Francoise
    Mallebranche, Coralie
    Barthez-Toullec, Malika
    Denti, Lamia
    Ruhier, Kalaivani
    Andre-Bonnet, Marie-Helene
    Marie-Cardine, Aude
    Aladjidi, Nathalie
    Stephan, Jean-Louis
    [J]. FRONTIERS IN PEDIATRICS, 2023, 11